Science and Technology Science and Technology
Thu, January 16, 2025
[ Thu, Jan 16th ] - MSN
SpaceX launches two moon missions in one fell swoop
[ Thu, Jan 16th ] - Wired
A New Jam-Packed Biden Executive Order Tackles Cybersecurity, AI, and More
[ Thu, Jan 16th ] - MSN
Kerala SET admit card 2025 for January exam released, direct link here
[ Thu, Jan 16th ] - MSN
Jeff Bezos' Blue Origin launches massive New Glenn rocket on first test flight and reaches orbit
[ Thu, Jan 16th ] - MSN
Jeff Bezos' Blue Origin launches massive New Glenn rocket on first test flight
[ Thu, Jan 16th ] - Scroll
Kerala SET admit card 2025 released; here's download link
[ Thu, Jan 16th ] - UPI
Blue Origin successfully launches New Glenn rocket
[ Thu, Jan 16th ] - MSN
Funds for virology building assured
[ Thu, Jan 16th ] - NDTV
NASA's James Webb Space Telescope Shows 3D Structure Of Dust And Gas Between Stars
[ Thu, Jan 16th ] - MSN
Science Ministry, Asean agree on $30M project to foster digital innovation in region
[ Thu, Jan 16th ] - MSN
Oyo: Makinde approves new appointment of 902 civil servants
[ Thu, Jan 16th ] - MSN
Masterstroke by Modi govt as US removes 3 Indian .. from..., bad news for China as over 11 Chinese...
[ Thu, Jan 16th ] - MSN
SpaceX Launches Two Private Lunar Landers: A Mile .. Exploration and NASA's Long-Term Lunar Ambitions
[ Thu, Jan 16th ] - MSN
New Method Transforms Scrap Aluminum into High-Performance Alloys
[ Thu, Jan 16th ] - MSN
US removes sanctions on BARC, two other Indian companies
Wed, January 15, 2025
[ Wed, Jan 15th ] - MSN
Seven CoEs being set up to bolster higher education in Kerala: Minister R Bindu
[ Wed, Jan 15th ] - MSN
Oak Ridge National Lab on the cutting edge of AI use and research
[ Wed, Jan 15th ] - MSN
China unveils 'Crimson Skyblade' in nuclear fusion quest for unlimited clean energy
[ Wed, Jan 15th ] - MSN
DOST appeals for funding to finish construction of virus research center
[ Wed, Jan 15th ] - MSN
Generative AI simplifies science communication, boosts public trust in scientists
[ Wed, Jan 15th ] - deseret
Trump's Energy nominee says he wants to 'restore our energy dominance'
[ Wed, Jan 15th ] - cnycentral
Senator Schumer announces $825M final agreement for Albany Nanotech
[ Wed, Jan 15th ] - MSN
Micron's rapid gains in HBM and DRAM rattle South Korean rivals
[ Wed, Jan 15th ] - MSN
Deccan eruptions: How lava sparked a tropical floral revival
[ Wed, Jan 15th ] - MSN
Scientists successfully demonstrated long-lasting quantum entanglement between molecules
[ Wed, Jan 15th ] - MSN
2 privately built moon landers carried into space by SpaceX rocket
[ Wed, Jan 15th ] - MSN
New technology gives us a look into the future of .. s and transportation: 'No longer science fiction'
[ Wed, Jan 15th ] - MSN
Do The Benefits of AI Justify The Costs? Here Are 6 Questions You Need to Ask Before You Commit
[ Wed, Jan 15th ] - MSN
UW initiative 'Society + Technology' aims to foster broad collaboration at critical intersection
[ Wed, Jan 15th ] - MSN
AbbVie and Simcere Zaiming link to develop trispecific antibody

AbbVie and Simcere Zaiming link to develop trispecific antibody


Published on 2025-01-15 17:22:26 - MSN
  Print publication without navigation

  • The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory MM.

AbbVie, a leading biopharmaceutical company, has entered into a collaboration with Simcere Zaiming, a Chinese biotech firm, to develop a trispecific antibody aimed at treating cancer. This partnership leverages Simcere Zaiming's expertise in trispecific T cell-engaging antibodies, which are designed to simultaneously target three different antigens, potentially enhancing the effectiveness of cancer immunotherapy. The agreement includes AbbVie making an upfront payment to Simcere Zaiming, with further milestone payments and royalties on future sales if the product successfully reaches the market. This collaboration not only signifies AbbVie's commitment to expanding its oncology portfolio but also highlights the growing trend of international partnerships in the biotech industry to accelerate drug development.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biology/abbvie-and-simcere-zaiming-link-to-develop-trispecific-antibody/ar-AA1xgBc4 ]
Contributing Sources